$NVRO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEVRO CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEVRO CORP. Get notifications about new insider transactions in NEVRO CORP for free.
Page: < prev 1 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Option Exercise | M | 3.60 | 17,587 | 63,313 | 94,501 | |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Option Exercise | M | 3.60 | 46,505 | 167,418 | 112,088 | |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 96.18 | 27,925 | 2,685,947 | 485,920 | 513.8 K to 485.9 K (-5.43 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 95.82 | 18,579 | 1,780,305 | 513,845 | 532.4 K to 513.8 K (-3.49 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Buy | M | 63.23 | 18,750 | 1,185,563 | 532,424 | 513.7 K to 532.4 K (+3.65 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Buy | M | 18.00 | 27,754 | 499,572 | 513,674 | 485.9 K to 513.7 K (+5.71 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 98.86 | 7,906 | 781,608 | 485,920 | 493.8 K to 485.9 K (-1.60 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 97.86 | 38,599 | 3,777,368 | 493,826 | 532.4 K to 493.8 K (-7.25 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Buy | M | 18.00 | 28,918 | 520,524 | 532,425 | 503.5 K to 532.4 K (+5.74 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Buy | M | 3.60 | 17,587 | 63,313 | 503,507 | 485.9 K to 503.5 K (+3.62 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 102.29 | 200 | 20,458 | 485,920 | 486.1 K to 485.9 K (-0.04 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 101.45 | 700 | 71,015 | 486,120 | 486.8 K to 486.1 K (-0.14 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 100.12 | 5,450 | 545,625 | 486,820 | 492.3 K to 486.8 K (-1.11 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 99.00 | 7,600 | 752,427 | 492,270 | 499.9 K to 492.3 K (-1.52 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 97.98 | 20,784 | 2,036,460 | 499,870 | 520.7 K to 499.9 K (-3.99 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 97.30 | 11,771 | 1,145,371 | 520,654 | 532.4 K to 520.7 K (-2.21 %) |
Oct 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Buy | M | 3.60 | 46,505 | 167,418 | 532,425 | 485.9 K to 532.4 K (+9.57 %) |
Oct 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 83,108 | |
Oct 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 100.46 | 100 | 10,046 | 37,963 | 38.1 K to 38 K (-0.26 %) |
Oct 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 100.01 | 600 | 60,003 | 38,063 | 38.7 K to 38.1 K (-1.55 %) |
Oct 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 98.64 | 800 | 78,914 | 38,663 | 39.5 K to 38.7 K (-2.03 %) |
Oct 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
Sep 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 84,608 | |
Sep 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 96.94 | 1,100 | 106,637 | 37,963 | 39.1 K to 38 K (-2.82 %) |
Sep 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 95.93 | 400 | 38,370 | 39,063 | 39.5 K to 39.1 K (-1.01 %) |
Sep 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
Aug 24 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 100.00 | 2,000 | 200,000 | 1,690 | 3.7 K to 1.7 K (-54.20 %) |
Aug 24 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 100.00 | 1,000 | 100,000 | 5,961 | 7 K to 6 K (-14.37 %) |
Aug 24 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 99.00 | 3,334 | 330,066 | 4,255 | 7.6 K to 4.3 K (-43.93 %) |
Aug 24 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 99.00 | 3,334 | 330,066 | 72,554 | 75.9 K to 72.6 K (-4.39 %) |
Aug 24 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 99.00 | 6,666 | 659,934 | 485,920 | 492.6 K to 485.9 K (-1.35 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 99.89 | 79 | 7,891 | 25,797 | 25.9 K to 25.8 K (-0.31 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.58 | 137 | 13,505 | 25,876 | 26 K to 25.9 K (-0.53 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 99.89 | 3,567 | 356,305 | 1,168,321 | 1.2 M to 1.2 M (-0.30 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.58 | 6,217 | 612,841 | 1,171,888 | 1.2 M to 1.2 M (-0.53 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.30 | 370 | 36,372 | 26,013 | 26.4 K to 26 K (-1.40 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.86 | 1,034 | 101,192 | 26,383 | 27.4 K to 26.4 K (-3.77 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.30 | 16,753 | 1,646,874 | 1,178,105 | 1.2 M to 1.2 M (-1.40 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.86 | 46,843 | 4,584,276 | 1,194,858 | 1.2 M to 1.2 M (-3.77 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.14 | 50 | 4,907 | 27,417 | 27.5 K to 27.4 K (-0.18 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.53 | 1,459 | 142,300 | 27,467 | 28.9 K to 27.5 K (-5.04 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.88 | 216 | 20,926 | 28,926 | 29.1 K to 28.9 K (-0.74 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.14 | 2,250 | 220,807 | 1,241,701 | 1.2 M to 1.2 M (-0.18 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.53 | 66,066 | 6,443,576 | 1,243,951 | 1.3 M to 1.2 M (-5.04 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.88 | 9,799 | 949,341 | 1,310,017 | 1.3 M to 1.3 M (-0.74 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.16 | 661 | 63,559 | 29,142 | 29.8 K to 29.1 K (-2.22 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.16 | 29,953 | 2,880,143 | 1,319,816 | 1.3 M to 1.3 M (-2.22 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.06 | 73 | 7,086 | 29,803 | 29.9 K to 29.8 K (-0.24 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.02 | 457 | 43,880 | 29,876 | 30.3 K to 29.9 K (-1.51 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.06 | 3,327 | 322,932 | 1,349,769 | 1.4 M to 1.3 M (-0.25 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.02 | 20,689 | 1,986,494 | 1,353,096 | 1.4 M to 1.4 M (-1.51 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.66 | 121 | 11,938 | 30,333 | 30.5 K to 30.3 K (-0.40 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.90 | 2,039 | 199,617 | 30,454 | 32.5 K to 30.5 K (-6.28 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.66 | 5,487 | 541,339 | 1,373,785 | 1.4 M to 1.4 M (-0.40 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.90 | 92,353 | 9,041,331 | 1,379,272 | 1.5 M to 1.4 M (-6.28 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 18.00 | 5,047 | 90,846 | 46,852 | |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 3.60 | 2,374 | 8,546 | 42,430 | |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 3.60 | 79 | 284 | 62,861 | |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 98.85 | 100 | 9,885 | 30,000 | 30.1 K to 30 K (-0.33 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 98.09 | 3,194 | 313,286 | 30,100 | 33.3 K to 30.1 K (-9.59 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 97.39 | 4,206 | 409,620 | 33,294 | 37.5 K to 33.3 K (-11.22 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 18.00 | 5,047 | 90,846 | 37,500 | 32.5 K to 37.5 K (+15.55 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 3.60 | 2,374 | 8,546 | 32,453 | 30.1 K to 32.5 K (+7.89 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 3.60 | 79 | 284 | 30,079 | 30 K to 30.1 K (+0.26 %) |
Aug 12 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 95.00 | 1,500 | 142,500 | 3,690 | 5.2 K to 3.7 K (-28.90 %) |
Aug 12 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 95.00 | 1,500 | 142,500 | 3,690 | 5.2 K to 3.7 K (-28.90 %) |
Aug 12 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 95.00 | 1,000 | 95,000 | 6,961 | 8 K to 7 K (-12.56 %) |
Aug 12 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 95.00 | 1,000 | 95,000 | 6,961 | 8 K to 7 K (-12.56 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 94.00 | 3,334 | 313,396 | 7,589 | 10.9 K to 7.6 K (-30.52 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 89.00 | 3,333 | 296,637 | 10,923 | 14.3 K to 10.9 K (-23.38 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 94.00 | 3,334 | 313,396 | 75,888 | 79.2 K to 75.9 K (-4.21 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 89.00 | 3,333 | 296,637 | 79,222 | 82.6 K to 79.2 K (-4.04 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 94.00 | 6,666 | 626,604 | 492,586 | 499.3 K to 492.6 K (-1.34 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 89.00 | 6,667 | 593,363 | 499,252 | 505.9 K to 499.3 K (-1.32 %) |
Aug 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 86,108 | |
Aug 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 82.06 | 1,500 | 123,094 | 37,963 | 39.5 K to 38 K (-3.80 %) |
Aug 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
Aug 02 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 84.00 | 3,333 | 279,972 | 14,256 | 17.6 K to 14.3 K (-18.95 %) |
Aug 02 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 84.00 | 3,333 | 279,972 | 82,555 | 85.9 K to 82.6 K (-3.88 %) |
Aug 02 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 84.00 | 6,667 | 560,028 | 505,919 | 512.6 K to 505.9 K (-1.30 %) |
Aug 02 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 85.00 | 1,000 | 85,000 | 7,961 | 9 K to 8 K (-11.16 %) |
Jul 12 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 80.00 | 1,000 | 80,000 | 5,190 | 6.2 K to 5.2 K (-16.16 %) |
Jul 12 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 80.00 | 1,000 | 80,000 | 8,961 | 10 K to 9 K (-10.04 %) |
Jul 12 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 79.00 | 3,333 | 263,307 | 17,589 | 20.9 K to 17.6 K (-15.93 %) |
Jul 12 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 79.00 | 3,333 | 263,307 | 85,888 | 89.2 K to 85.9 K (-3.74 %) |
Jul 12 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 79.00 | 6,667 | 526,693 | 512,586 | 519.3 K to 512.6 K (-1.28 %) |
Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 87,608 | |
Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 87,608 | |
Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 75.80 | 400 | 30,321 | 37,963 | 38.4 K to 38 K (-1.04 %) |
Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 75.80 | 400 | 30,321 | 37,963 | 38.4 K to 38 K (-1.04 %) |
Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 75.24 | 1,100 | 82,761 | 38,363 | 39.5 K to 38.4 K (-2.79 %) |
Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 75.24 | 1,100 | 82,761 | 38,363 | 39.5 K to 38.4 K (-2.79 %) |
Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
Jul 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 74.00 | 3,333 | 246,642 | 20,922 | 24.3 K to 20.9 K (-13.74 %) |
Jul 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 74.00 | 3,333 | 246,642 | 89,221 | 92.6 K to 89.2 K (-3.60 %) |
Jul 06 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 74.00 | 6,667 | 493,358 | 519,253 | 525.9 K to 519.3 K (-1.27 %) |
Jun 10 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 1.44 | 6,000 | 8,640 | 29,422 | |
Jun 10 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 77.00 | 2,000 | 154,000 | 961 | 3 K to 961 (-67.54 %) |
Jun 10 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 76.00 | 2,000 | 152,000 | 2,961 | 5 K to 3 K (-40.31 %) |
Jun 10 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 75.00 | 2,000 | 150,000 | 4,961 | 7 K to 5 K (-28.73 %) |
Jun 10 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 1.44 | 6,000 | 8,640 | 6,961 | 961 to 7 K (+624.35 %) |
Jun 10 2016 | NVRO | NEVRO CORP | Elghandour Rami | President & CEO | Option Exercise | M | 3.60 | 7,000 | 25,200 | 78,051 | |
Jun 10 2016 | NVRO | NEVRO CORP | Elghandour Rami | President & CEO | Sell | S | 77.45 | 600 | 46,467 | 64,180 | 64.8 K to 64.2 K (-0.93 %) |
Jun 10 2016 | NVRO | NEVRO CORP | Elghandour Rami | President & CEO | Sell | S | 76.74 | 5,545 | 425,499 | 64,780 | 70.3 K to 64.8 K (-7.88 %) |
Jun 10 2016 | NVRO | NEVRO CORP | Elghandour Rami | President & CEO | Sell | S | 75.04 | 855 | 64,161 | 70,325 | 71.2 K to 70.3 K (-1.20 %) |
Jun 10 2016 | NVRO | NEVRO CORP | Elghandour Rami | President & CEO | Buy | M | 3.60 | 7,000 | 25,200 | 71,180 | 64.2 K to 71.2 K (+10.91 %) |
Jun 10 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 75.00 | 1,000 | 75,000 | 9,961 | 11 K to 10 K (-9.12 %) |
Jun 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 89,108 | |
Jun 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 73.29 | 1,500 | 109,942 | 37,963 | 39.5 K to 38 K (-3.80 %) |
Jun 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
Jun 03 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 1.44 | 764 | 1,100 | 35,422 | |
Jun 03 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Option Exercise | M | 1.44 | 3,236 | 4,660 | 36,186 | |
Jun 03 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 74.00 | 764 | 56,536 | 961 | 1.7 K to 961 (-44.29 %) |
Jun 03 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 1.44 | 764 | 1,100 | 1,725 | 961 to 1.7 K (+79.50 %) |
Jun 03 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 74.00 | 1,236 | 91,464 | 961 | 2.2 K to 961 (-56.26 %) |
Jun 03 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Sell | S | 73.00 | 2,000 | 146,000 | 2,197 | 4.2 K to 2.2 K (-47.65 %) |
Jun 03 2016 | NVRO | NEVRO CORP | Walker Andre | Senior VP,Research& ... | Buy | M | 1.44 | 3,236 | 4,660 | 4,197 | 961 to 4.2 K (+336.73 %) |
Jun 03 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality and Ope ... | Sell | S | 72.00 | 500 | 36,000 | 6,190 | 6.7 K to 6.2 K (-7.47 %) |
May 20 2016 | NVRO | NEVRO CORP | Vale Brad | Director | Option Exercise | A | 63.39 | 3,240 | 205,384 | 3,240 | |
May 20 2016 | NVRO | NEVRO CORP | McCormick Shawn | Director | Option Exercise | A | 63.39 | 3,240 | 205,384 | 3,240 | |
May 20 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Option Exercise | A | 63.39 | 3,240 | 205,384 | 3,240 | |
May 20 2016 | NVRO | NEVRO CORP | Fischer Frank M | Director | Option Exercise | A | 63.39 | 3,240 | 205,384 | 3,240 | |
May 20 2016 | NVRO | NEVRO CORP | Earnhardt Lisa D | Director | Option Exercise | A | 63.39 | 3,240 | 205,384 | 3,240 | |
May 20 2016 | NVRO | NEVRO CORP | Behbahani Ali | Director | Option Exercise | A | 63.39 | 3,240 | 205,384 | 3,240 | |
May 19 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 64.02 | 29 | 1,857 | 32,493 | 32.5 K to 32.5 K (-0.09 %) |
May 19 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 64.02 | 1,314 | 84,121 | 1,471,625 | 1.5 M to 1.5 M (-0.09 %) |
May 19 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 65.54 | 78 | 5,112 | 32,522 | 32.6 K to 32.5 K (-0.24 %) |
May 19 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 64.01 | 174 | 11,137 | 32,600 | 32.8 K to 32.6 K (-0.53 %) |
May 19 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 65.54 | 3,522 | 230,818 | 1,472,939 | 1.5 M to 1.5 M (-0.24 %) |
May 19 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 64.01 | 7,866 | 503,479 | 1,476,461 | 1.5 M to 1.5 M (-0.53 %) |
May 19 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 65.47 | 91 | 5,957 | 32,774 | 32.9 K to 32.8 K (-0.28 %) |
May 19 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 64.68 | 2,069 | 133,813 | 32,865 | 34.9 K to 32.9 K (-5.92 %) |
May 19 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 65.47 | 4,140 | 271,033 | 1,484,327 | 1.5 M to 1.5 M (-0.28 %) |
May 19 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 64.68 | 93,700 | 6,060,048 | 1,488,467 | 1.6 M to 1.5 M (-5.92 %) |
May 18 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 64.77 | 6,666 | 431,783 | 24,255 | 30.9 K to 24.3 K (-21.56 %) |
May 18 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 64.77 | 6,666 | 431,783 | 92,554 | 99.2 K to 92.6 K (-6.72 %) |
May 18 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Chief Executive Off ... | Sell | S | 64.77 | 26,667 | 1,727,326 | 525,920 | 552.6 K to 525.9 K (-4.83 %) |
May 18 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 1.44 | 10,000 | 14,400 | 27,404 | |
May 18 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 64.78 | 10,000 | 647,847 | 30,000 | 40 K to 30 K (-25.00 %) |
May 18 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 1.44 | 10,000 | 14,400 | 40,000 | 30 K to 40 K (+33.33 %) |
May 16 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | M | 3.60 | 3,156 | 11,362 | 85,051 | |
May 16 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Option Exercise | M | 3.60 | 3,844 | 13,838 | 119,546 | |
May 16 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Sell | S | 65.13 | 300 | 19,540 | 64,180 | 64.5 K to 64.2 K (-0.47 %) |
May 16 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Sell | S | 64.15 | 5,051 | 324,009 | 64,480 | 69.5 K to 64.5 K (-7.26 %) |
May 16 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Sell | S | 63.06 | 1,649 | 103,978 | 69,531 | 71.2 K to 69.5 K (-2.32 %) |
May 16 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Buy | M | 3.60 | 3,156 | 11,362 | 71,180 | 68 K to 71.2 K (+4.64 %) |
May 16 2016 | NVRO | NEVRO CORP | Elghandour Rami | President | Buy | M | 3.60 | 3,844 | 13,838 | 68,024 | 64.2 K to 68 K (+5.99 %) |
May 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Option Exercise | M | 3.60 | 1,500 | 5,400 | 90,608 | |
May 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Sell | S | 65.84 | 440 | 28,969 | 37,413 | 37.9 K to 37.4 K (-1.16 %) |